Summit Therapeutics PLC (SMMT) — Cash Flow Quality Index

Latest as of June 2018: -0.38x

Summit Therapeutics PLC (SMMT) has a Cash Flow Quality Index of -0.38x as of June 2018. Operating cash flow of $-13.86 Million is below net income of $36.06 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Summit Therapeutics PLC (SMMT) total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.38x
Operating CF / Net Income

Operating Cash Flow

$-13.86 Million
USD

Net Income

$36.06 Million
USD

Data as of

Jun 2018
Most recent filing

Summit Therapeutics PLC Cash Flow Quality Index (2018–2018)

Historical Cash Flow Quality Index for Summit Therapeutics PLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Summit Therapeutics PLC (SMMT) tangible net worth to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Summit Therapeutics PLC (2018–2018)

Year-by-year earnings quality comparison for Summit Therapeutics PLC. For live market cap and the full company financial profile, see how much is Summit Therapeutics PLC worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
2018 -3.23x $-35.11 Million $10.87 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.